InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Blasticidin | Developing synthetic tools to decipher the tumor-immune interactome. | 2023 | PNAS | Weizman O.E. et al. | DOI: 10.1073/pnas.2306632120 |
| G418 (Geneticin) | Developing synthetic tools to decipher the tumor-immune interactome. | 2023 | PNAS | Weizman O.E. et al. | DOI: 10.1073/pnas.2306632120 |
| Puromycin | Developing synthetic tools to decipher the tumor-immune interactome. | 2023 | PNAS | Weizman O.E. et al. | DOI: 10.1073/pnas.2306632120 |
| LyoVec™ | The parapoxvirus Orf virus inhibits dsDNA-mediated type I IFN expression via ... | 2023 | J Gen Virol. | AlDaif B.A. et al. | DOI: 10.1099/jgv.0.001912 |
| Primocin® | Organoids transplantation attenuates intestinal ischemia/reperfusion injury i... | 2023 | Nat Commun. | Zhang F.L. et al. | DOI: 10.1038/s41467-023-42502-0 |
| EndoFit Ovalbumin | Immune synapse formation promotes lipid peroxidation and MHC-I upregulation i... | 2023 | Nat Commun. | Calzada-Fraile D. et al. | DOI: 10.1038/s41467-023-42480-3 |
| Human ACE2 & TMPRSS2 expressing A549 Cells | An interferon-integrated mucosal vaccine provides pan-sarbecovirus protection... | 2023 | Nat Commun. | Yuen C.K. et al. | DOI: 10.1038/s41467-023-42349-5 |
| LPS-EB VacciGrade™ | Protocol for cytokine and uterine immune cell characterization in a mouse mod... | 2023 | STAR Protoc. | Wayland J.L. et al. | DOI: 10.1016/j.xpro.2023.102643 |
| Primocin® | Sympathetic activity regulates epithelial proliferation and wound healing via... | 2023 | Sci Rep. | Ten Hove A.S. et al. | DOI: 10.1038/s41598-023-45160-w |
| LPS-EK (LPS from E. coli K12) | Immune Activation Profiles Elicited by Distinct, Repeated TLR Agonist Infusio... | 2023 | J Immunol. | King H.A.D. et al. | DOI: 10.4049/jimmunol.2300424 |
| Poly(I:C) LMW | Immunogenicity of rabies virus G mRNA formulated with lipid nanoparticles and... | 2023 | Vaccine | Hongtu Q. et al. | DOI: 10.1016/j.vaccine.2023.10.019 |
| LPS-EB (LPS from E. coli O111:B4) | A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-infla... | 2023 | Nat Commun. | Boeszoermenyi A. et al. | DOI: 10.1038/s41467-023-42070-3 |
| L18-MDP | A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-infla... | 2023 | Nat Commun. | Boeszoermenyi A. et al. | DOI: 10.1038/s41467-023-42070-3 |
| R848 (Resiquimod) | A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-infla... | 2023 | Nat Commun. | Boeszoermenyi A. et al. | DOI: 10.1038/s41467-023-42070-3 |
| 2'3'-cGAMP | A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-infla... | 2023 | Nat Commun. | Boeszoermenyi A. et al. | DOI: 10.1038/s41467-023-42070-3 |
| ssRNA40/LyoVec™ | A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-infla... | 2023 | Nat Commun. | Boeszoermenyi A. et al. | DOI: 10.1038/s41467-023-42070-3 |
| C12-iE-DAP | A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-infla... | 2023 | Nat Commun. | Boeszoermenyi A. et al. | DOI: 10.1038/s41467-023-42070-3 |
| Poly(I:C) HMW | A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-infla... | 2023 | Nat Commun. | Boeszoermenyi A. et al. | DOI: 10.1038/s41467-023-42070-3 |
| THP1-Dual™ Cells | A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-infla... | 2023 | Nat Commun. | Boeszoermenyi A. et al. | DOI: 10.1038/s41467-023-42070-3 |
| QUANTI-Blue™ | A conformation-locking inhibitor of SLC15A4 with TASL proteostatic anti-infla... | 2023 | Nat Commun. | Boeszoermenyi A. et al. | DOI: 10.1038/s41467-023-42070-3 |